In the event of disagreement on the application of the classification rules between the manufacturer of an in vitro diagnostic medical device and an authorised body involved in the conformity assessment procedures provided for in this Title, the Director General of the Agence nationale de sécurité du médicament et des produits de santé shall determine the certification procedure to which the device in question is subject.